![](/img/cover-not-exists.png)
1315PDevelopment and internal validation of a predictive nomogram of progression-free survival in well-differentiated stage IV gastroenteropancreatic neuroendocrine tumours treated with somatostatin analogues: GETNE-TRASGU study
Garcia-Carbonero, R, Alonso, V, Capdevila, J, Sanchez Canovas, M, Alonso, T, Benavent, M, Custodio, A, Crespo Herrero, G, Lopez, C, Hernando, J, Riesco Martinez, M C, Escudero, P, Gallego Plazas, J, MVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy293.008
Date:
October, 2018
File:
PDF, 79 KB
2018